Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), is a liver disease worldwide without approved therapeutic drugs. Anti-inflammatory and hepatoprotective drug bicyclol and multi-pharmacological active drug berberine, respectively, have sh...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hu Li, Nan-Nan Liu, Jian-Rui Li, Biao Dong, Mei-Xi Wang, Jia-Li Tan, Xue-Kai Wang, Jing Jiang, Lei Lei, Hong-Ying Li, Han Sun, Jian-Dong Jiang, Zong-Gen Peng
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Pharmacology
Assuntos:	nonalcoholic fatty liver disease bicyclol berberine combination lipid metabolism gut microbiota
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2022.843872/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!